Literature DB >> 20606444

Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe.

Witold A Zatoński1, Urszula Sulkowska, Marta Mańczuk, Jürgen Rehm, Paolo Boffetta, Albert B Lowenfels, Carlo La Vecchia.   

Abstract

BACKGROUND AND AIMS: Over the last decades, Europe has experienced dramatic changes in the geographical variation of liver cirrhosis rates. We attempt to provide a comprehensive analysis of patterns and trends in liver cirrhosis mortality in European countries and regions.
METHODS: Age-standardized (world standard) liver cirrhosis mortality rates per 100,000 person-years at ages 20-64 for 35 separate countries were computed using the World Health Organization Mortality Database.
RESULTS: In the analyzed period (1959-2002), a very strong East-to-West gradient in mortality rates was observed. An increase of the burden of mortality due to liver cirrhosis appeared in Eastern Europe in two specific areas: South-eastern Europe and North-eastern Europe. In the first group of countries, liver cirrhosis mortality was 10-20 times higher than in most other European states, levels never before observed in Europe. In the countries of North-eastern Europe (former Soviet Union countries) liver cirrhosis mortality was characterized by dramatic changes (both positive and negative) in specific periods of time.
CONCLUSIONS: Despite the fact that the etiology of liver cirrhosis is multifactorial, it seems that alcohol drinking is the factor that best explains the observed patterns in frequency of this disease in Europe. Alcohol control policies in Central and Eastern Europe could lead to an appreciable reduction of premature mortality from liver cirrhosis.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 20606444     DOI: 10.1159/000317248

Source DB:  PubMed          Journal:  Eur Addict Res        ISSN: 1022-6877            Impact factor:   3.015


  42 in total

Review 1.  Binge drinking: Burden of liver disease and beyond.

Authors:  Susana Llerena; María Teresa Arias-Loste; Angela Puente; Joaquín Cabezas; Javier Crespo; Emilio Fábrega
Journal:  World J Hepatol       Date:  2015-11-28

Review 2.  Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.

Authors:  Silvia Berardis; Prenali Dwisthi Sattwika; Mustapha Najimi; Etienne Marc Sokal
Journal:  World J Gastroenterol       Date:  2015-01-21       Impact factor: 5.742

3.  Alcohol Consumption and Risk of Liver Cirrhosis: A Systematic Review and Meta-Analysis.

Authors:  Michael Roerecke; Afshin Vafaei; Omer S M Hasan; Bethany R Chrystoja; Marcus Cruz; Roy Lee; Manuela G Neuman; Jürgen Rehm
Journal:  Am J Gastroenterol       Date:  2019-10       Impact factor: 10.864

4.  Alcoholic disease: understanding the scope of the problem and what we need to do to tackle it.

Authors:  Helena Cortez-Pinto
Journal:  Ther Adv Chronic Dis       Date:  2012-03       Impact factor: 5.091

5.  Autologous mobilized peripheral blood CD34(+) cell infusion in non-viral decompensated liver cirrhosis.

Authors:  Mithun Sharma; Padaki Nagaraja Rao; Mitnala Sasikala; Mamata Reddy Kuncharam; Chimpa Reddy; Vardaraj Gokak; Bpss Raju; Jagdeesh R Singh; Piyal Nag; D Nageshwar Reddy
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

6.  Can alcohol control policies reduce cirrhosis mortality? An interrupted time-series analysis in Lithuania.

Authors:  Alexander Tran; Huan Jiang; Shannon Lange; Jakob Manthey; Mindaugas Štelemėkas; Robertas Badaras; Janina Petkevičienė; Ričardas Radišauskas; Robin Room; Jürgen Rehm
Journal:  Liver Int       Date:  2022-01-30       Impact factor: 5.828

Review 7.  New determinants of prognosis in bacterial infections in cirrhosis.

Authors:  Juan Acevedo; Javier Fernández
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

Review 8.  Alcohol liver disease: A review of current therapeutic approaches to achieve long-term abstinence.

Authors:  María Luisa Gutiérrez García; Sara Blasco-Algora; Conrado M Fernández-Rodríguez
Journal:  World J Gastroenterol       Date:  2015-07-28       Impact factor: 5.742

Review 9.  Recommendations on the Diagnosis and Initial Management of Acute Variceal Bleeding and Hepatorenal Syndrome in Patients with Cirrhosis.

Authors:  Frederik Nevens; Paulo Lisboa Bittencourt; Minneke J Coenraad; Huiguo Ding; Ming-Chih Hou; Pierre-François Laterre; Manuel Mendizabal; Nayeli Xochiquetzal Ortiz-Olvera; Julio D Vorobioff; Wenhong Zhang; Paolo Angeli
Journal:  Dig Dis Sci       Date:  2019-01-25       Impact factor: 3.199

10.  The von Willebrand Factor antigen to platelet ratio (VITRO) score predicts hepatic decompensation and mortality in cirrhosis.

Authors:  Rémy Schwarzer; Thomas Reiberger; Mattias Mandorfer; Danijel Kivaranovic; Silvia Hametner; Stephanie Hametner; Rafael Paternostro; Bernhard Scheiner; Jenifer Schneeweiss-Friedl; Michael Trauner; Rainer Schoefl; Andreas Maieron
Journal:  J Gastroenterol       Date:  2019-12-12       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.